Cystatin C in children on chronic hemodialysis

Pediatric Nephrology

Volumn 28, Issue 4, 2013, Pages 647-653

  Marsenic, Olivera ^a   Wierenga, Andrea ^a   Wilson, Donna R ^a   Anderson, Michael ^a   Shrivastava, Tripti ^a   Simon, Garfield A ^a   Beck, Anne M ^a   Swanson, Tiffany J ^a   Studnicka, Kathleen ^a   Elberg, Dorit ^a   Couloures, Kevin ^a   Turman, Martin A ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Biomarkers; Glomerular filtration rate; Hemodialysis adequacy; Pediatric hemodialysis; Residual renal function

Indexed keywords

C REACTIVE PROTEIN; CREATININE; CYSTATIN C; STEROID; THYROTROPIN; BIOLOGICAL MARKER; CST3 PROTEIN, HUMAN;

ACUTE DISEASE; ADOLESCENT; ADULT; ANURIA; ARTICLE; BLOOD VOLUME; BODY HEIGHT; CHILD; CLINICAL ARTICLE; CREATININE CLEARANCE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; KINETICS; PRESCHOOL CHILD; PRIORITY JOURNAL; RESIDUAL RENAL FUNCTION; SCHOOL CHILD; THYROID FUNCTION TEST; ULTRAFILTRATION; URINE VOLUME; AGE; BLOOD; CHRONIC KIDNEY FAILURE; KIDNEY; KIDNEY FUNCTION TEST; PATHOPHYSIOLOGY; PILOT STUDY; RENAL REPLACEMENT THERAPY; STATISTICAL MODEL; TREATMENT OUTCOME; UPREGULATION;

ADOLESCENT; AGE FACTORS; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CYSTATIN C; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KINETICS; LINEAR MODELS; PILOT PROJECTS; RENAL DIALYSIS; TREATMENT OUTCOME; UP-REGULATION; YOUNG ADULT;

MLCS; MLOWN;

EID: 84879924374     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-012-2366-7     Document Type: Article

References (41)

1. Sharma AP, Kathiravelu A, Nadarajah R, Yasin A, Filler G (2009) Body mass does not have a clinically relevant effect on cystatin C eGFR in children. Nephrol Dial Transplant 24:470-474
2. Huang SH, Filler G, Yasin A, Lindsay RM (2011) Cystatin C reduction ratio depends on normalized blood liters processed and fluid removal during hemodialysis. Clin J Am Soc Nephrol 6:319-325
3. Zaffanello M, Franchini M, Fanos V (2007) Is serum Cystatin-C a suitable marker of renal function in children? Ann Clin Lab Sci 37:233-240
4. Tenstad O, Roald AB, Grubb A, Aukland K (1996) Renal handling of radiolabelled human cystatin C in the rat. Scand J Clin Lab Invest 56:409-414
5. Bacchetta J, Cochat P, Rognant N, Ranchin B, Hadj-Aissa A, Dubourg L (2011) Which creatinine and cystatin C equations can be reliably used in children? Clin J Am Soc Nephrol 6:552-560
6. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS, Investigators CKD-EPI (2012) Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367:20-29
7. Sjöström P, Tidman M, Jones I (2005) Determination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans. Scand J Clin Lab Invest 65:111-124
8. Sjöström PA, Jones IL, Tidman MA (2009) Cystatin C as a filtration marker: haemodialysis patients expose its strengths and limitations. Scand J Clin Lab Invest 69:65-72
9. Andersen TB, Jødal L, Boegsted M, Erlandsen EJ, Morsing A, Frøkiær J, Brøchner-Mortensen J (2011) GFR prediction from Cystatin C and Creatinine in children: effect of including body cell mass. Am J Kidney Dis 59:50-57
10. Sharma AP, Yasin A, Garg AX, Filler G (2011) Diagnostic accuracy of Cystatin C-based eGFR equations at different GFR levels in children. Clin J Am Soc Nephrol 6:1599-1608
11. Patel PC, Ayers CR, Murphy SA, Peshock R, Khera A, de Lemos JA, Balko JA, Gupta S, Mammen PP, Drazner MH, Markham DW (2009) Association of cystatin C with left ventricular structure and function: the Dallas Heart Study. Circ Heart Fail 2:98-104
12. Codoñer-Franch P, Ballester-Asensio E, Martínez-Pons L, Vallecillo-Hernández J, Navarro-Ruíz A, Valle-Pérez R (2011) Cystatin C, cardiometabolic risk, and body composition in severely obese children. Pediatr Nephrol 26:301-307
13. Ix JH, Shlipak MG, Chertow GM, Whooley MA (2007) Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation 115:173-179
14. Menon V, Shlipak MG, Wang X, Coresh J, Greene T, Stevens L, Kusek JW, Beck GJ, Collins AJ, Levey AS, Sarnak MJ (2007) Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med 147:19-27
15. Shin MJ, Song SH, Kwak IS, Lee SB, Lee DW, Seong EY, Kim IY, Rhee H, Lee N (2012) Serum cystatin C as a predictor for cardiovascular events in end-stage renal disease patients at the initiation of dialysis. Clin Exp Nephrol 16:456-463
16. Imai A, Komatsu S, Ohara T, Kamata T, Yoshida J, Miyaji K, Shimizu Y, Takewa M, Hirayama A, Deshpande GA, Takahashi O, Kodama K (2011) Serum cystatin C is associated with early stage coronary atherosclerotic plaque morphology on multidetector computed tomography. Atherosclerosis 218:350-355
17. Taglieri N, Koenig W, Kaski JC (2009) Cystatin C and cardiovascular risk. Clin Chem 55:1932-1943
18. Al-Malki N, Heidenheim PA, Filler G, Yasin A, Lindsay RM (2009) Cystatin C levels in functionally anephric patients undergoing dialysis: the effect of different methods and intensities. Clin J Am Soc Nephrol 4:1606-1610
19. Park JS, Kim GH, Kang CM, Lee CH (2010) Application of Cystatin C reduction ratio to high-flux Hemodialysis as an alternative indicator of the clearance of middle molecules. Korean J Intern Med 25:77-81
20. Krieter DH, Hackl A, Rodriguez A, Chenine L, Moragues HL, Lemke HD, Wanner C, Canaud B (2010) Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration. Nephrol Dial Transplant 25:212-218
21. Lindstrom V, Grubb A, Hegbrant MA, Christensson A (2008) Different elimination patterns of b-trace protein, b2-microglobulin and cystatin C in haemodialysis, haemodiafiltration and haemofiltration. Scand J Clin Lab Invest 68:685-691
22. Hoek FJ, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT (2007) Estimation of residual glomerular filtration rate in dialysis patients from the plasma cystatin C level. Nephrol Dial Transplant 22:1633-1638
23. Kim SJ, Sohn YB, Park SW, Jin DK, Paik KH (2011) Serum Cystatin C for estimation of residual renal function in children on peritoneal dialysis. Pediatr Nephrol 26:433-440
24. Filler G, Huang SS, Lindsay RM (2011) Residual renal function assessment with cystatin C. Pediatr Nephrol 26:333-335
25. Goldstein SL, Currier H, Watters L, Hempe JM, Sheth RD, Silverstein D (2003) Acute and chronic inflammation in pediatric patients receiving hemodialysis. J Pediatr 143:653-657
26. Grubb A, Björk J, Nyman U, Pollak J, Bengzon J, Ostner G, Lindström V (2011) Cystatin C, a marker for successful aging and glomerular filtration rate, is not influenced by inflammation. Scand J Clin Lab Invest 71:145-149
27. Özden TA, Tekerek H, Bafl F, Darendeliler F (2010) Effect of hypo-and euthyroid status on serum cystatin C levels. J Clin Res Ped Endo 2:155-158
28. Manetti L, Pardini E, Genovesi M, Campomori A, Grasso L, Morselli LL, Lupi I, Pellegrini G, Bartalena L, Bogazzi F, Martino E (2005) Thyroid function differently affects serum cystatin C and creatinine concentrations. J Endocrinol Invest 28:346-349
29. European best practice guidelines for haemodialysis (part 1) (2002) Measurement of residual renal function in HD. Nephrol Dial Transplant 17:11-15
30. Gehan E, George SL (1970) Estimation of human body surface area from height and weight. Cancer Chemother Rep 54:225-235
31. Daugirdas JT (1993) Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 4:1205-1213
32. KDOQI Clinical practice guidelines for hemodialysis adequacy (2006) Guideline 3. Methods for postdialysis blood sampling. Am J Kidney Dis 48:S24-S27
33. Fischbach M, Fothergill H, Zaloszyc A, Menouer S, Terzic J (2011) Intensified daily dialysis: the best chronic dialysis option for children? Semin Dial 24:640-644
34. Fischbach M, Fothergill H, Zaloszyc A, Seuge L (2012) Hemodiafiltration: the addition of convective flow to hemodialysis. Pediatr Nephrol 27:351-356
35. Fischbach M, Hamel G, Koehl C, Geisert J (1989) Beta-2-microglobulin in hemodiafiltered children: long-term efficiency follow-up. Nephron 53:110-114
36. Bökenkamp A, Domanetzki M, Zinck R, Schumann G, Brodehl J (1998) Reference values for cystatin C serum concentrations in children. Pediatr Nephrol 12:125-129
37. Köttgen A, Selvin E, Stevens LA, Levey AS, Van Lente F, Coresh J (2008) Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 51:385-394
38. Mitsnefes MM (2012) Cardiovascular disease in children with chronic kidney disease. J Am Soc Nephrol 23:578-585
39. North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) (2011) Dialysis patient characteristics. In: NAPRTCS (ed) Annual dialysis report. NAPRTCS, Boston, pp 1-18
40. Newman DJ (2002) Cystatin C. Ann Clin Biochem 39:89-104
41. Bökenkamp A, Herget-Rosenthal S, Bökenkamp R (2006) Cystatin C, kidney function and cardiovascular disease. Pediatr Nephrol 21:1223-1230